table of content
1 Study Coverage
1.1 Imatinib Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Imatinib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsules
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Imatinib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Imatinib Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Imatinib Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Imatinib Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Imatinib Drugs Sales by Region
2.4.1 Global Imatinib Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Imatinib Drugs by Region (2023-2028)
2.5 Global Imatinib Drugs Revenue by Region
2.5.1 Global Imatinib Drugs Revenue by Region (2017-2022)
2.5.2 Global Imatinib Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Imatinib Drugs Sales by Manufacturers
3.1.1 Global Top Imatinib Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Imatinib Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imatinib Drugs in 2021
3.2 Global Imatinib Drugs Revenue by Manufacturers
3.2.1 Global Imatinib Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Imatinib Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2021
3.3 Global Imatinib Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Imatinib Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Imatinib Drugs Sales by Type
4.1.1 Global Imatinib Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Imatinib Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Imatinib Drugs Sales Market Share by Type (2017-2028)
4.2 Global Imatinib Drugs Revenue by Type
4.2.1 Global Imatinib Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Imatinib Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Imatinib Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Imatinib Drugs Price by Type
4.3.1 Global Imatinib Drugs Price by Type (2017-2022)
4.3.2 Global Imatinib Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Imatinib Drugs Sales by Application
5.1.1 Global Imatinib Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Imatinib Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Imatinib Drugs Sales Market Share by Application (2017-2028)
5.2 Global Imatinib Drugs Revenue by Application
5.2.1 Global Imatinib Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Imatinib Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Imatinib Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Imatinib Drugs Price by Application
5.3.1 Global Imatinib Drugs Price by Application (2017-2022)
5.3.2 Global Imatinib Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Imatinib Drugs Market Size by Type
6.1.1 North America Imatinib Drugs Sales by Type (2017-2028)
6.1.2 North America Imatinib Drugs Revenue by Type (2017-2028)
6.2 North America Imatinib Drugs Market Size by Application
6.2.1 North America Imatinib Drugs Sales by Application (2017-2028)
6.2.2 North America Imatinib Drugs Revenue by Application (2017-2028)
6.3 North America Imatinib Drugs Market Size by Country
6.3.1 North America Imatinib Drugs Sales by Country (2017-2028)
6.3.2 North America Imatinib Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Imatinib Drugs Market Size by Type
7.1.1 Europe Imatinib Drugs Sales by Type (2017-2028)
7.1.2 Europe Imatinib Drugs Revenue by Type (2017-2028)
7.2 Europe Imatinib Drugs Market Size by Application
7.2.1 Europe Imatinib Drugs Sales by Application (2017-2028)
7.2.2 Europe Imatinib Drugs Revenue by Application (2017-2028)
7.3 Europe Imatinib Drugs Market Size by Country
7.3.1 Europe Imatinib Drugs Sales by Country (2017-2028)
7.3.2 Europe Imatinib Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Imatinib Drugs Market Size by Type
8.1.1 Asia Pacific Imatinib Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Imatinib Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Imatinib Drugs Market Size by Application
8.2.1 Asia Pacific Imatinib Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Imatinib Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Imatinib Drugs Market Size by Region
8.3.1 Asia Pacific Imatinib Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Imatinib Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Imatinib Drugs Market Size by Type
9.1.1 Latin America Imatinib Drugs Sales by Type (2017-2028)
9.1.2 Latin America Imatinib Drugs Revenue by Type (2017-2028)
9.2 Latin America Imatinib Drugs Market Size by Application
9.2.1 Latin America Imatinib Drugs Sales by Application (2017-2028)
9.2.2 Latin America Imatinib Drugs Revenue by Application (2017-2028)
9.3 Latin America Imatinib Drugs Market Size by Country
9.3.1 Latin America Imatinib Drugs Sales by Country (2017-2028)
9.3.2 Latin America Imatinib Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drugs Market Size by Type
10.1.1 Middle East and Africa Imatinib Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Imatinib Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Imatinib Drugs Market Size by Application
10.2.1 Middle East and Africa Imatinib Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Imatinib Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Imatinib Drugs Market Size by Country
10.3.1 Middle East and Africa Imatinib Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Imatinib Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Overview
11.1.3 Apotex Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Apotex Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Apotex Inc. Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Corporation Information
11.3.2 Sanofi S.A. Overview
11.3.3 Sanofi S.A. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi S.A. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi S.A. Recent Developments
11.4 Cipla Inc.
11.4.1 Cipla Inc. Corporation Information
11.4.2 Cipla Inc. Overview
11.4.3 Cipla Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Inc. Recent Developments
11.5 Mylan Pharms Inc.
11.5.1 Mylan Pharms Inc. Corporation Information
11.5.2 Mylan Pharms Inc. Overview
11.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Pharms Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Pharms Inc. Recent Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.6.2 Glenmark Pharmaceuticals Ltd. Overview
11.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Corporation Information
11.7.2 Sun Pharmaceuticals Overview
11.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharmaceuticals Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharmaceuticals Recent Developments
11.8 Actavis Generics
11.8.1 Actavis Generics Corporation Information
11.8.2 Actavis Generics Overview
11.8.3 Actavis Generics Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Actavis Generics Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Actavis Generics Recent Developments
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Corporation Information
11.9.2 Dr. Reddy's Laboratories Overview
11.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dr. Reddy's Laboratories Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddy's Laboratories Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.10.2 Teva Pharmaceutical Industries Ltd. Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Imatinib Drugs Industry Chain Analysis
12.2 Imatinib Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drugs Production Mode & Process
12.4 Imatinib Drugs Sales and Marketing
12.4.1 Imatinib Drugs Sales Channels
12.4.2 Imatinib Drugs Distributors
12.5 Imatinib Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Imatinib Drugs Industry Trends
13.2 Imatinib Drugs Market Drivers
13.3 Imatinib Drugs Market Challenges
13.4 Imatinib Drugs Market Restraints
14 Key Findings in The Global Imatinib Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
